Aurora Cannabis Dominates 30% Of Canada’s Medical Marijuana Exports: Will Its Bold International Expansion Pay Off?
Aurora Cannabis (NASDAQ:ACB) saw its international sales for the first half of 2024 reach C$39.3 million ($28.9 million), reflecting a 31% year-over-year increase. This growth includes the full acquisition of MedReleaf Australia in February 2024, which contributed significantly to the sales boost. A Wednesday report by Pablo Zuanic of Zuanic & Associates provides a detailed analysis of the company’s recent activities and financial standing.
International Sales And Market Position
Aurora remains a leader in the export of Canadian medical marijuana (MMJ), accounting for more than 30% of Canada’s MMJ exports.
Key markets include Australia, Germany, Israel, Czechia and Portugal, …